Search

TIGR Director J. Craig Venter, in the Sorcerer, undertakes sailing across the Atlantic along the same path as Columbus' Second Voyage

TIGR Director J. Craig Venter, in the Sorcerer, undertakes sailing across the Atlantic along the same path as Columbus' Second Voyage

TIGR's founder and its Board chairman, J. Craig Venter, has been elected to the National Academy of Sciences in recognition of his "distinguished and continuing achievements in original research."

TIGR's founder and its Board chairman, J. Craig Venter, has been elected to the National Academy of Sciences in recognition of his "distinguished and continuing achievements in original research."

Statement from J. Craig Venter, Ph.D., on the Presidential Commission for the Study of Bioethical Issues Report, "New Directions: The Ethics of Synthetic Biology and Emerging Technologies"

"The J. Craig Venter Institute (JCVI) commends the Presidential Commission for the Study of Bioethical Issues (Commission) for their extensive work that resulted in their report on the ethical and societal issues raised by synthetic biology and genomics. We believe that the Commission's report is comprehensive and that their recommendations are wise, warranted and restrained which will help to ensure that this young field of research will flourish in a positive manner. I and my team at...

McCarthy Completes Construction of J. Craig Venter Institute’s Landmark Net-Zero-Energy Genomic Laboratory in La Jolla

J. Craig Venter Institute Education Program Fosters Learning Opportunities with Salisbury University Students and Faculty

Patti Erickson, PhD first connected with the J. Craig Venter Institute (JCVI) in the Fall of 2016 as an associate professor at Salisbury University looking for opportunities to expose undergraduate students to biology outside of the classroom. Soon thereafter, she and a group from Salisbury visited JCVI’s Rockville labs, forging a relationship that would lead her to working in the lab of Sanjay Vashee, PhD as a visiting scientist while on sabbatical. Her work at JCVI, which is ongoing,...

CLC bio Signs Strategic Collaborative Agreement with J. Craig Venter Institute

Cambridge, Massachusetts, USA — October 7, 2008 — CLC bio, a world leading full-service bioinformatics solution provider announced today an agreement with the J. Craig Venter Institute, a not-for profit genomic-focused research institute. The accord consists of a multi-year site license for the entire CLC bio bioinformatics suite of products. The goal is to implement CLC bio's enterprise solution as a scientific platform across all JCVI sites. This enterprise solution will...

Human Longevity, Inc. and Venter Institute Scientists Publish Paper Demonstrating Inconsistency in Microbiome Studies due to Variable Approaches to DNA Sequencing and Data Analysis

From Sequencing to Sailing: Three Decades of Adventure with Craig Venter

Multimillion Dollar NIH Grant Pairs Venter Institute and the NYU College of Dentistry on Study to Predict Caries Risk

J. Craig Venter Institute extends CLC bio site license through 2017

Aarhus, Denmark -- January 8, 2013 -- Today CLC bio, the global leader in commercial sequence analysis software, announced that the J. Craig Venter Institute (JCVI) has extended their site license agreement with CLC bio through 2017. JCVI has been utilizing CLC bio’s enterprise platform since 2009 and currently uses it on more than 30 research grants, including their work as part of the Human Microbiome Project (HMP). The HMP is a National Institutes of Health-funded project to...